Next |
home / stock / ctxr / ctxr message board
Subject | By | Source | When |
---|---|---|---|
$CTXR Time for a bounce? | Jayzp | investorshub | 05/03/2023 10:41:05 PM |
$CTXR The now up | sushifishman | investorshub | 05/03/2023 3:17:52 PM |
When is this gonna take off? | unityriver | investorshub | 05/02/2023 5:06:21 AM |
Price now last trade up | gwsteller | investorshub | 04/28/2023 5:53:06 AM |
bulls and bears | FROZENFLAME | investorshub | 04/27/2023 2:41:01 PM |
Lets go go go go... Up up and away we go. | drkazmd65 | investorshub | 04/25/2023 12:40:20 AM |
Ther Vs ctxr | Jayzp | investorshub | 04/24/2023 12:55:23 PM |
$CTXR best news of the day | drkazmd65 | investorshub | 04/23/2023 1:49:17 PM |
$CTXR just the news we needed | Foxwoods Man | investorshub | 04/22/2023 5:43:16 PM |
best guess is that a large holder sold | dtgsanjose | investorshub | 04/22/2023 2:22:42 AM |
The gaining | longboarder7892 | investorshub | 04/22/2023 2:13:54 AM |
Interesting trading day here today. I can't | drkazmd65 | investorshub | 04/21/2023 3:44:00 PM |
Found an interesting article | budfoxfun | investorshub | 04/18/2023 12:21:01 PM |
When is this gonna take off? | Diana15 | investorshub | 04/17/2023 11:41:51 AM |
$CTXR short squeeze signal | longtrailer | investorshub | 04/12/2023 6:49:13 PM |
bears and bulls | KJAX | investorshub | 04/12/2023 5:00:14 PM |
$CTXR news out | mypenneys | investorshub | 04/12/2023 11:19:36 AM |
Good read | dtgsanjose | investorshub | 04/10/2023 11:28:42 AM |
$CTXR Lets go go go go... Up up and away we go. | FROZENFLAME | investorshub | 04/09/2023 5:23:59 AM |
$CTXR MomentumIts gaining | shurtha2000 | investorshub | 04/09/2023 4:41:16 AM |
News, Short Squeeze, Breakout and More Instantly...
Citius Pharmaceuticals Inc. Company Name:
CTXR Stock Symbol:
NASDAQ Market:
Citius Pharmaceuticals (NASDAQ: CTXR) is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The company's diversified pipeline includes two late-stage product candidates. At the end of 2023, Citius completed enrollm...
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update PR Newswire Mino-Lok data analysis on track with topline results anticipated this quarter LYMPHIR biologics license application accepted with PDUFA target action da...
Citius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences PR Newswire CRANFORD, N.J. , May 10, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical ...